CN103642766A - Protein, DNA molecule, conversion host containing DNA and method for production of L-valine by utilization of conversion host - Google Patents
Protein, DNA molecule, conversion host containing DNA and method for production of L-valine by utilization of conversion host Download PDFInfo
- Publication number
- CN103642766A CN103642766A CN201310275401.3A CN201310275401A CN103642766A CN 103642766 A CN103642766 A CN 103642766A CN 201310275401 A CN201310275401 A CN 201310275401A CN 103642766 A CN103642766 A CN 103642766A
- Authority
- CN
- China
- Prior art keywords
- dna molecular
- valine
- conversion
- seq
- function equivalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 34
- 229960004295 valine Drugs 0.000 title abstract description 49
- 238000004519 manufacturing process Methods 0.000 title abstract description 16
- 108090000623 proteins and genes Proteins 0.000 title abstract description 4
- 102000004169 proteins and genes Human genes 0.000 title abstract description 3
- 108020004414 DNA Proteins 0.000 title abstract 4
- 102000053602 DNA Human genes 0.000 title abstract 2
- 108010028658 Leucine Dehydrogenase Proteins 0.000 claims abstract description 25
- 239000002773 nucleotide Substances 0.000 claims abstract description 22
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 22
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 45
- 239000004474 valine Substances 0.000 claims description 45
- 150000001413 amino acids Chemical group 0.000 claims description 26
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 7
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 7
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 7
- 238000006555 catalytic reaction Methods 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 238000011218 seed culture Methods 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 5
- 238000012262 fermentative production Methods 0.000 claims description 4
- NLJVXZFCYKWXLH-DXTIXLATSA-N 3-[(3r,6s,9s,12s,15s,17s,20s,22r,25s,28s)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N[C@H](CC=2C=CC=CC=2)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)N1)=O)CC(C)C)C(C)C)C1=CC=C(O)C=C1 NLJVXZFCYKWXLH-DXTIXLATSA-N 0.000 claims description 2
- 108010021006 Tyrothricin Proteins 0.000 claims description 2
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 229960003281 tyrothricin Drugs 0.000 claims description 2
- 235000014393 valine Nutrition 0.000 claims 2
- 150000003680 valines Chemical class 0.000 claims 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 14
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 101100342797 Geobacillus stearothermophilus ldh gene Proteins 0.000 abstract description 6
- 230000001580 bacterial effect Effects 0.000 abstract description 6
- 230000006870 function Effects 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108090000340 Transaminases Proteins 0.000 description 5
- 102000003929 Transaminases Human genes 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 241000194107 Bacillus megaterium Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000005693 branched-chain amino acids Chemical class 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 241000572303 Corynebacterium pekinense Species 0.000 description 3
- 108700016168 Dihydroxy-acid dehydratases Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000012269 metabolic engineering Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108010088278 Branched-chain-amino-acid transaminase Proteins 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 101100493587 Escherichia coli (strain K12) avtA gene Proteins 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 108010000200 Ketol-acid reductoisomerase Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 101710157860 Oxydoreductase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 101150099953 ilvE gene Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940049547 paraxin Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 101150028338 tyrB gene Proteins 0.000 description 1
- 108010037084 valine-pyruvate transaminase Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
- C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
- C12Y104/01—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
- C12Y104/01009—Leucine dehydrogenase (1.4.1.9)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the biotechnology field, and especially relates to a protein, a DNA molecule, a conversion host containing the DNA and a method for production of L-valine by utilization of the conversion host. A coding gene leuDH (the nucleotide sequence is shown in SEQ ID No.2) of a leucine dehydrogenase with an auxiliary factor of NADH is converted and introduced into corynebacteria, and genetically engineered bacterium with changed redox equilibrium in cells are obtained. The bacterial strain is cultured and can be used for production of L-valine, and the yield of L-valine is raised remarkably.
Description
Technical field
The present invention relates to biological technical field, particularly the DNA molecular of albumen, this albumen of encoding, contain this DNA molecular this conversion of conversion host host for the production of the method for Valine.
Background technology
Valine (L-valine), chemical name is L-valine, molecular formula is C
5h
11nO
2, relative molecular mass is 117.15.Be white in color crystallization or crystalline powder, odorless, bitter, solubleness in water: 25 ℃ is 88.5g/L, and 50 ℃ is 96.2g/L, is insoluble to cold ethanol, ether, acetone.Iso-electric point is 5.96,315 ℃ of fusing points.Valine (L-Val) is one of eight kinds of indispensable amino acids of human body, again one of three kinds of branched-chain amino acids (comprising α-amino-isovaleric acid, leucine, Isoleucine), because of its special structure and function, in human life's metabolism, there is the status of particularly important.Can be widely used in medicine industry, foodstuffs industry and fodder industry etc.In medicine industry, the main component of amino acid transfusion, comprehensive amino acid preparation can be made, liver failure, central nervous system function disorder can be treated.As lacked, can cause neurological disorder, stasi, weight loss, anaemia etc.In foodstuffs industry, can be used as foodstuff additive, liquid and flavour agent etc. are augmented in nutrition.In metric system cake, add α-amino-isovaleric acid (1g/kg), product has sesame fragrant, for bread, also can improve local flavor.Valine also can be used as amino acid energy beverage and sports drink, has the muscle of formation, strengthens liver function, alleviates the effects such as muscle fatigue.In fodder industry, the mammary tissue lactation of animal is had to important promoter action.Use it in chicken feed, can improve the immunological competence of chick to newcastle disease virus.And Valine is a kind of limiting amino acid in animal-feed, so Valine can be used as the deficiency that fodder additives improves aminoacids content in animal diets.
The production method of Valine has three kinds: extraction method, chemical synthesis, microbe fermentation method.Extraction method and chemical synthesis, because raw material sources are restricted, production cost is high, contaminate environment, are difficult to realize suitability for industrialized production.Production by Microorganism Fermentation Valine has that raw materials cost is low, reaction conditions is gentle, easily realize the advantages such as scale operation, is to produce at present the topmost method of Valine.By the seed selection of bacterial strain, to remove the feedback inhibition in metabolism adjusting and to check, reach the object of excess accumulation Valine, be microbe fermentation method industrial application means the most widely.
Rod bacillus is for the production of L-amino acid whose representative microorganism, particularly Corynebacterium glutamicum (Corynebacterium glutamicum), Beijing corynebacterium (Corynebacterium pekinense) and brevibacterium flavum (Breviabacterium flavum).Yet the output that existing strain fermentation is produced Valine is lower, cannot meet the need of market.
In order to improve the Valine throughput of microorganism, can to producing bacterial strain, constantly transform by methods such as traditional mutagenesis and metabolic engineerings.Tradition selection by mutation, refer to by specific starting strain being carried out to physics, chemistry or the two merging ground mutagenic treatment, select again auxotroph and/or Amino acid analogue resistant mutant strain, to remove the feedback inhibition in metabolism adjusting or to check effect, thereby reach certain amino acid whose object of excess accumulation.Metabolic engineering breeding adopts genetic engineering technique engineered cells metabolic system to improve efficiency of pcr product or to improve cell performance exactly on to the basis of metabolism network systems analysis.Mainly comprise following means: to the structure of the transformation of original pathways metabolism, novel metabolic pathways, the metabolism critical path of group scale or the identification of target spot.Metabolic engineering by rationality builds amino acid preparation strain, becomes just gradually the main policies of amino acid breeding.
Summary of the invention
In view of this, the invention provides a kind of albumen, this albumen of encoding DNA molecular, contain this DNA molecular this conversion of conversion host host for the production of the method for Valine.Encoding gene leuDH by the leucine dehydrogenase that is NADH by cofactor transforms in introduction rod bacillus, obtain the genetic engineering bacterium that in born of the same parents, redox equilibrium changes, cultivate this bacterial strain and can be used in production Valine, the utmost point has significantly improved the output of Valine.
In order to realize foregoing invention object, the invention provides following technical scheme:
The invention provides a kind of leucine dehydrogenase or its function equivalent with the aminoacid sequence as shown in SEQ ID No.1.
The metabolic pathway of synthesizing of α-amino-isovaleric acid, is from dimolecular pyruvic acid, through three intermediate products such as acetylactis, dihydroxyl isovaleric acid and ketone group isovaleric acid, finally forms α-amino-isovaleric acid.And these mesostates respectively catalytic activity by acetohydroxy acid synthetase, Acetohydroxy acid isomeroreductase, dihydroxyacid dehydratase and transaminase produce, as shown in Figure 1.
Acetohydroxy acid synthetase (AHAS) is that first the shared enzyme on Valine route of synthesis is also key enzyme, and 1 molecule acetylactis, the i.e. precursor of α-amino-isovaleric acid are synthesized in catalysis 2 molecule pyruvic acid decarboxylations.AHAS is subject to any feedback inhibition in three kinds of branched-chain amino acids.
Dihydroxy acid reduction isomerase (AHAIR) is second enzyme on Valine route of synthesis, is a tetramer enzyme, and the subunit of the same race that is 53kDa by size forms, and catalysis acetylactis generates 2,3-dihydroxyl isovaleric acid.Reaction comprises isomery and the reduction of alkyl; There is this reaction and also need Mg
2+(activator) and NADPH (hydrogen donor).
Dihydroxyacid dehydratase (DHAD) is the 3rd enzyme on Valine route of synthesis, and the dimer enzyme being comprised of two subunits can catalysis 2, and 3-dihydroxyl isovaleric acid generates 2-ketone group isovaleric acid.
Transaminase (TA) B is last enzyme in α-amino-isovaleric acid building-up process.Transaminase B, Transaminase C and aromatic aminotransferase (gene is respectively ilvE, avtA and tyrB) all have catalytic activity in branched-chain amino acid synthetic, but mainly by three kinds of synthetic final steps of branched-chain amino acid of Transaminase B catalysis, are reacted.
Leucine dehydrogenase (Leucine Dehydrogenase, LDH, EC1.4.1.9) is a kind of NAD
+the oxydo-reductase of dependent form, it is catalysis L-Leu and corresponding ketone acid and the analogue thereof of some branched-chain l-amino acids reaction generation reversibly, as follows:
The leucine dehydrogenase that derives from bacillus megaterium (Bacillus megaterium) ATCC14945 has good thermostability, chemical stability and operational stability.
NADH and NADPH are important coenzyme in cell, most redox reactions of involved in sugar, fat, protein three class substance metabolisms, and NAD/NADH and NADP/NADPH are respectively its corresponding redox couples.The leucine dehydrogenase encoding gene leuDH that derives from bacillus megaterium is imported in excellent bacillus or Flavobacterium, and its coded product be take NADH as coenzyme.The expression of this enzyme can supplement and take the function of the transaminase that NADPH is coenzyme originally as coenzyme with NADH, thereby reduce the consumption to NADPH, reach the effect of the balance that regulates the interior NADH of born of the same parents and NADPH, the result that transforms and express is to make also corresponding being changed of the interior redox equilibrium of born of the same parents.
As preferably, the function equivalent with the leucine dehydrogenase of the aminoacid sequence as shown in SEQ ID No.1 provided by the invention obtains by replacing in the aminoacid sequence shown in SEQ ID No.1, lacking or add one or more amino-acid residues.
The present invention also provides leucine dehydrogenase or its function equivalent with the aminoacid sequence as shown in SEQ ID No.1 for catalysis 2-ketone group isovaleric acid, to generate the application of α-amino-isovaleric acid.
The present invention also provides coding to have the leucine dehydrogenase of aminoacid sequence or the DNA molecular of its function equivalent as shown in SEQ ID No.1.
In some embodiments of the invention, coding provided by the invention has the leucine dehydrogenase of the aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular nucleotide sequence of its function equivalent as shown in SEQ ID No.2.
The present invention also provides coding to have the leucine dehydrogenase of aminoacid sequence or the DNA molecular of its function equivalent as shown in SEQ ID No.1, and the homology of the nucleotide sequence shown in its nucleotide sequence and SEQ ID No.2 is greater than more than 95%.
The present invention also provides coding to have the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the carrier of the DNA molecular of its function equivalent; Coding has the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular of its function equivalent can be greater than more than 95% DNA molecular for the DNA molecular of nucleotide sequence as shown in SEQ ID No.2 or the homology of the nucleotide sequence shown in nucleotide sequence and SEQ ID No.2.
In some embodiments of the invention, coding has the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the carrier of the DNA molecular of its function equivalent is pMX119.
The present invention also provides coding to have the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the conversion host of the DNA molecular of its function equivalent; Coding has the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular of its function equivalent can be greater than more than 95% DNA molecular for the DNA molecular of nucleotide sequence as shown in SEQ ID No.2 or the homology of the nucleotide sequence shown in nucleotide sequence and SEQ ID No.2.
In some embodiments of the invention, coding has the DNA molecular that the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular of its function equivalent can be greater than more than 95% for the homology of the DNA molecular of nucleotide sequence as shown in SEQ ID No.2 or the nucleotide sequence shown in nucleotide sequence and SEQ ID No.2 and imports by the conversion method that shocks by electricity.
In some embodiments of the invention, coding has the DNA molecular that the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular of its function equivalent can be greater than more than 95% for the homology of the DNA molecular of nucleotide sequence as shown in SEQ ID No.2 or the nucleotide sequence shown in nucleotide sequence and SEQ ID No.2 and expresses enhancing.
As preferably, express the mode that strengthens and can be greater than for the homology of the DNA molecular of nucleotide sequence as shown in SEQ ID No.2 or the nucleotide sequence shown in nucleotide sequence and SEQ ID No.2 more than 95% DNA molecular as under the control of strong promoter or increase its copy number for coding has the leucine dehydrogenase of aminoacid sequence as shown in SEQ ID No.1 or the DNA molecular of its function equivalent.
In some embodiments of the invention, transforming host is excellent bacillus or tyrothricin.
In other embodiment of the present invention, transforming host is excellent bacillus, its deposit number for its deposit number be CGMCC No.7041.
The present invention also provides above-mentioned conversion host the purposes for fermentative production Valine.
The present invention also provides the method for above-mentioned conversion host fermentative production Valine, it is characterized in that, gets after described conversion host increases in seed culture medium, is placed in fermention medium and cultivates 50～120h in 28 ℃～37 ℃, obtains.
The invention provides a kind of albumen, the DNA molecular of this albumen of encoding, contain this DNA molecular this conversion of conversion host host for the production of the method for Valine.Encoding gene leuDH by the leucine dehydrogenase that is NADH by cofactor transforms in introduction rod bacillus, obtains the genetic engineering bacterium that in born of the same parents, redox equilibrium changes, and cultivates this bacterial strain and can be used in production Valine.In the fermented liquid of shake flask fermentation, the Valine output of starting strain CGMCC1.299 is 1.2g/L, and the Valine output of excellent bacillus provided by the invention is 3.8g/L, than starting strain output, improves 216%.In the fermented liquid of 50L tank, the Valine output of starting strain CGMCC1.299 is 2.9g/L, and the Valine output of excellent bacillus provided by the invention is 9.1g/L, than starting strain output, improve 213.7%, the utmost point has significantly improved Valine output (P < 0.01).Comprehensive above-mentioned fermentation test result, the excellent bacillus that deposit number provided by the invention the is CGMCCNo.7041 all utmost point has significantly improved Valine output (P < 0.01).
Biological preservation explanation
Classification And Nomenclature: Beijing corynebacterium Corynebacterium pekinense is deposited in China Committee for Culture Collection of Microorganisms's common micro-organisms center on December 26th, 2012, address is No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, deposit number for its deposit number be CGMCC No.7041.
accompanying drawing explanation
Fig. 1 shows Valine biosynthesizing route map;
Fig. 2 shows the schematic diagram of recombinant plasmid pXMJ19-leuDH.
Embodiment
The invention discloses a kind of albumen, the DNA molecular of this albumen of encoding, contain this DNA molecular this conversion of conversion host host for the production of the method for Valine.Those skilled in the art can use for reference content herein, suitably improve processing parameter and realize.Special needs to be pointed out is, all similar replacements and change apparent to those skilled in the artly, they are all deemed to be included in the present invention.Method of the present invention and application are described by preferred embodiment, related personnel obviously can change methods and applications as herein described or suitably change and combination within not departing from content of the present invention, spirit and scope, realizes and apply the technology of the present invention.
The DNA molecular of albumen provided by the invention, this albumen of encoding, this conversion of conversion host host of containing this DNA molecular all can be buied by market for the production of agents useful for same in the method for Valine.Wherein, the deposit number of starting strain is CGMCC1.299.
Below in conjunction with embodiment, further set forth the present invention:
The structure of embodiment 1 expression plasmid pXMJ19-leuDH
1. the genomic dna of bacillus megaterium Bacillus megaterium ATCC14945 of take is template, with the primer pair that leuF and leuR form, carries out pcr amplification, obtains pcr amplification product:
LeuF:5-' G
aAGCTTaTGAAAATTTTTGACTAT-3 ' (underscore is that HindIII enzyme is cut recognition site)
LeuR:5-' C
gAATTCtTAGCGCGTATGACGTCTAC-3 ' (underscore is that EcoRI enzyme is cut recognition site)
2. the PCR product of recycling step 1 link carrier pEASY
tM-T5 (purchased from Beijing Quanshijin Biotechnology Co., Ltd), obtains recombinant plasmid pT5-leuDH, and order-checking obtains leuDH gene order, as shown in SEQ ID No.1;
3. with two kinds of restriction enzymes (HindIII and EcoRI) double digestion plasmid pT5-leuDH and carrier pXMJ19, cut after glue reclaims and obtain respectively leuDH fragment (about 1100bp) and pXMJ19 carrier framework (about 6600bp);
4. two double digestion products of step 3 gained are connected, transform intestinal bacteria, LB culture medium flat plate screening through containing 17 μ g/mL paraxin obtains positive colony, extracts recombinant plasmid pXMJ19-leuDH after amplification cultivation, and its structural representation as shown in Figure 2.
The structure of embodiment 2 engineering bacteria CGMCC1.299/pXMJ19-leuDH
1. prepare the electric shock transformed competence colibacillus cell of excellent bacillus;
2. electric shock transforms: the pXMJ19-leuDH plasmid of 3-8 μ L is joined in competent cell, place 10min on ice; Proceed to 1mm electric shock cup, 1.8 or 2.1kV electric shock 5-7ms;
3. add LB substratum 1mL, 33 ℃, 150rpm are cultivated 1h; After concentrated, coat containing on the brain heart culture medium flat plate of 25 μ g/mL kantlex 33 ℃ of constant temperature culture 36-48h;
4. screening positive clone, carries out PCR evaluation (specific band of the 1.1kb that has an appointment positive) by the primer pair with leuF/leuR forms, and obtains recombinant bacterium.
By recombinant bacterium called after Beijing corynebacterium (Corynebacterium pekinense) MHZ-1010, this bacterial strain is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (being called for short CGMCC) on December 26th, 2012, and deposit number is CGMCC No.7041.
Embodiment 3 deposit number provided by the invention is that the excellent bacillus fermentation of CGMCC No.7041 is produced Valine
1. substratum
Seed activation substratum: yeast extract 1%, peptone 1%, sodium-chlor 0.5%, glucose 0.5%, agar 2%, pH7.2;
Seed culture medium: corn steep liquor 2.5%, glucose 1.0%, ammonium sulfate 0.4%, magnesium sulfate 0.04%, potassium primary phosphate 0.1%, urea 0.1%, CaCO
30.5%, pH7.2;
Fermention medium: corn steep liquor 0.5%, glucose 12.0%, ammonium sulfate 4.0%, magnesium sulfate 0.04%, potassium primary phosphate 0.1%, CaCO
34%, V
h50ug/L, V
b1hCl100 μ g/L, pH7.2;
2. shake flask fermentation is produced Valine
(1) seed culture: picking excellent bacillus provided by the invention inclined-plane seed 1 articulating is to being equipped with in the 500mL triangular flask of 20mL seed culture medium, 33 ℃, 220r/min shaking culture 16-22h;
(2) fermentation culture: 2mL seed liquor is seeded in the 500mL triangular flask that 20mL fermention medium is housed to 33 ℃, 220r/min shaking culture 72h; During 24h, adding IPTG(final concentration is 10 μ mol/L) induction;
(3) get 1mL fermented liquid centrifugal (12000rpm, 2min), collect supernatant liquor, with HPLC test bar bacillus and the Valine content contrasting in fermented liquid, its concentration is as shown in table 1.
The comparative result of Valine content in the fermented liquid of table 1 shake flask fermentation
As shown in data in table 1, the Valine output of starting strain CGMCC1.299 is 1.2g/L, and the Valine output of excellent bacillus provided by the invention is 3.8g/L, than starting strain output, improve 216%, the utmost point has significantly improved Valine output (P < 0.01).
3.50L tank fermentative production Valine
(1) secondary seed is cultivated: picking rod bacillus inclined-plane seed 2-3 articulating is to being equipped with in the 2L triangular flask of 100mL seed culture medium, 33 ℃, the about 12-16h of 220r/min shaking culture; Proceeded to again in the 5L triangular flask containing 1L nutrient solution 33 ℃, 220r/min continuation cultivation 16-20h;
(2) 50L fermentation: 3L seed liquor is seeded in the 50L fermentor tank that 22L fermention medium is housed, cultivates 72h for 31 ℃; In process, with ammoniacal liquor, regulate pH7.0, with the glucose of 80% (m/v), maintaining remaining sugar concentration is 2-3%, and dissolved oxygen is controlled between 10-20% relatively, and it is 10 μ mo l/L that 24h adds IPTG(final concentration constantly) induction;
(3) get 1mL fermented liquid centrifugal (12000rpm, 2min), collect supernatant liquor, HPLC test bar bacillus and the Valine content contrasting in fermented liquid, its concentration is as shown in table 2.
The comparative result of Valine content in the fermented liquid of table 250L tank
As shown in table 2, the Valine output of starting strain CGMCC1.299 is 2.9g/L, and the Valine output of excellent bacillus provided by the invention is 9.1g/L, than starting strain output, improve 213.7%, the utmost point has significantly improved Valine output (P < 0.01).
The above is only the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the premise without departing from the principles of the invention; can also make some improvements and modifications, these improvements and modifications also should be considered as protection scope of the present invention.
Claims (16)
1. leucine dehydrogenase or its function equivalent with the aminoacid sequence as shown in SEQ ID No.1.
2. function equivalent according to claim 1 obtains by replacing in the aminoacid sequence shown in SEQ ID No.1, lacking or add one or more amino-acid residues.
3. leucine dehydrogenase according to claim 1 and 2 or its function equivalent generate the application of α-amino-isovaleric acid for catalysis 2-ketone group isovaleric acid.
4. the DNA molecular of coding leucine dehydrogenase as claimed in claim 1 or 2 or its function equivalent.
5. DNA molecular according to claim 4, is characterized in that, its nucleotide sequence is as shown in SEQ ID No.2.
6. the DNA molecular of coding leucine dehydrogenase as claimed in claim 1 or 2 or its function equivalent, is characterized in that, the homology of the nucleotide sequence shown in its nucleotide sequence and SEQ ID No.2 is greater than more than 95%.
7. the carrier with the DNA molecular as described in claim 5 or 6 any one.
8. carrier according to claim 7, is characterized in that, it is pMX119.
9. the conversion host with the DNA molecular as described in claim 5 or 6 any one.
10. conversion host according to claim 9, is characterized in that, the DNA molecular as described in claim 5 or 6 any one imports by electric shock conversion method.
11. conversion hosts according to claim 9, is characterized in that, the DNA molecular as described in claim 5 or 6 any one is expressed and strengthened.
12. conversion hosts according to claim 11, it is characterized in that, the mode that described expression strengthens be DNA molecular as described in claim 5 or 6 any one as under the control of strong promoter or the copy number of the DNA molecular of increase as described in claim 5 or 6 any one.
13. conversion hosts according to claim 9, is characterized in that, it is excellent bacillus or tyrothricin.
14. conversion hosts according to claim 9, is characterized in that, its deposit number is CGMCC No.7041.
15. according to the conversion host described in claim 9 to 14 any one for the purposes of fermentative production Valine.
16. 1 kinds of excellent bacillus fermentations as described in claim 9 to 14 any one are produced the methods of Valines, it is characterized in that, get described conversions host in seed culture medium, expand numerous after, be placed in fermention medium in 28 ℃～37 ℃ cultivation 50～120h, obtain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310275401.3A CN103642766B (en) | 2013-07-02 | 2013-07-02 | Albumen, DNA molecular, convert host and this conversion host for the method producing L valine containing this DNA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310275401.3A CN103642766B (en) | 2013-07-02 | 2013-07-02 | Albumen, DNA molecular, convert host and this conversion host for the method producing L valine containing this DNA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103642766A true CN103642766A (en) | 2014-03-19 |
| CN103642766B CN103642766B (en) | 2016-12-28 |
Family
ID=50248053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310275401.3A Active CN103642766B (en) | 2013-07-02 | 2013-07-02 | Albumen, DNA molecular, convert host and this conversion host for the method producing L valine containing this DNA |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103642766B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113278641A (en) * | 2020-05-27 | 2021-08-20 | 安徽华恒生物科技股份有限公司 | Recombinant escherichia coli for producing L-valine, construction method and application thereof |
| CN113278655A (en) * | 2020-05-13 | 2021-08-20 | 安徽华恒生物科技股份有限公司 | Recombinant microorganism for producing L-valine and construction method and application thereof |
| WO2021238184A1 (en) * | 2020-05-27 | 2021-12-02 | 安徽华恒生物科技股份有限公司 | Recombinant microorganism for producing l-valine, construction method therefor and use thereof |
| CN113913478A (en) * | 2021-11-26 | 2022-01-11 | 江南大学 | Method for producing L-valine by fermenting Brevibacterium flavum |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6128398A (en) * | 1984-07-20 | 1986-02-08 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-valine |
| CN1380408A (en) * | 2001-04-10 | 2002-11-20 | 上海博德基因开发有限公司 | A polypeptide-Glu/Leu/Phe/Val dehydrogenase-11.55 and polynucleotide for coding this polypeptide |
| CN1982466A (en) * | 2005-12-12 | 2007-06-20 | 上海化工研究院 | Production of stabilized isotope 15N labelled L-valine |
| CN102399732A (en) * | 2011-12-13 | 2012-04-04 | 梅花生物科技集团股份有限公司 | Beijing corynebacterium and application thereof |
| CN102660482A (en) * | 2012-05-17 | 2012-09-12 | 通辽梅花生物科技有限公司 | Corynebacterium pekinense and application thereof |
-
2013
- 2013-07-02 CN CN201310275401.3A patent/CN103642766B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6128398A (en) * | 1984-07-20 | 1986-02-08 | Kyowa Hakko Kogyo Co Ltd | Preparation of l-valine |
| CN1380408A (en) * | 2001-04-10 | 2002-11-20 | 上海博德基因开发有限公司 | A polypeptide-Glu/Leu/Phe/Val dehydrogenase-11.55 and polynucleotide for coding this polypeptide |
| CN1982466A (en) * | 2005-12-12 | 2007-06-20 | 上海化工研究院 | Production of stabilized isotope 15N labelled L-valine |
| CN102399732A (en) * | 2011-12-13 | 2012-04-04 | 梅花生物科技集团股份有限公司 | Beijing corynebacterium and application thereof |
| CN102660482A (en) * | 2012-05-17 | 2012-09-12 | 通辽梅花生物科技有限公司 | Corynebacterium pekinense and application thereof |
Non-Patent Citations (10)
| Title |
|---|
| EPPINGER,M. ET AL.: "CP001983.1 Bacillus megaterium QM B1551, complete genome", 《GENBANK》 * |
| EPPINGER,M. ET AL.: "YP_003564886.1 butyryl-CoA dehydrogenase [Bacillus megaterium QM B1551]", 《NCBI REFERENCE SEQUENCE》 * |
| EPPINGER,M. ET AL.: "YP_003599608.1 butyryl-CoA dehydrogenase [Bacillus megaterium DSM 319]", 《NCBI REFERENCE SEQUENCE》 * |
| LIU,L.ET AL.: "CP003017.1 Bacillus megaterium WSH-002, complete genome", 《GENBANK》 * |
| 刘焕民 等: "L-缬氨酸生物合成的基础研究和菌种选育的进展", 《食品工业科技》 * |
| 屈明波 等: "L缬氨酸发酵供氧与补料过程控制的研究", 《生物工程学报》 * |
| 未提供: "WP_013059125.1 leucine dehydrogenase [Bacillus megaterium]", 《NCBI REFERENCE SEQUENCE》 * |
| 未提供: "WP_013084979.1", 《NCBI REFERENCE SEQUENCE》 * |
| 王小元: "谷氨酸棒杆菌生产缬氨酸的代谢工程研究进展", 《食品与生物技术学报》 * |
| 黄春辉 等: "亮氨酸脱氢酶研究进展及其工业应用", 《氨基酸和生物资源》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113278655A (en) * | 2020-05-13 | 2021-08-20 | 安徽华恒生物科技股份有限公司 | Recombinant microorganism for producing L-valine and construction method and application thereof |
| CN113278641A (en) * | 2020-05-27 | 2021-08-20 | 安徽华恒生物科技股份有限公司 | Recombinant escherichia coli for producing L-valine, construction method and application thereof |
| WO2021238183A1 (en) * | 2020-05-27 | 2021-12-02 | 安徽华恒生物科技股份有限公司 | Recombinant microorganism for producing l-valine, a construction method therefor, and application thereof |
| WO2021238184A1 (en) * | 2020-05-27 | 2021-12-02 | 安徽华恒生物科技股份有限公司 | Recombinant microorganism for producing l-valine, construction method therefor and use thereof |
| CN113913478A (en) * | 2021-11-26 | 2022-01-11 | 江南大学 | Method for producing L-valine by fermenting Brevibacterium flavum |
| CN113913478B (en) * | 2021-11-26 | 2023-06-02 | 江南大学 | Method for producing L-valine by fermenting Brevibacterium flavum |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103642766B (en) | 2016-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10975400B2 (en) | 5-aminolevulinic acid high-yield bacterial strain, preparation method and use thereof | |
| CN101501204B (en) | Method for producing amino acids using glycerol | |
| KR20190137060A (en) | Preparation of (R) -3-hydroxybutyric acid or salts thereof by one-step fermentation | |
| CN104862352A (en) | Microorganism producing O-phosphoserine and method of producing L-cysteine or derivatives thereof from O-phosphoserine using the same | |
| CN105385646A (en) | Precursor-directed biosynthesis of 5-hydroxytryptophan | |
| CN105907732A (en) | D-lactic dehydrogenase, engineering strain containing D-lactic dehydrogenase and construction method and use of engineering strain | |
| CN104593308A (en) | Genetic engineering strain, construction method and application in xylitol production | |
| CN105950529B (en) | Produce recombination Corynebacterium glutamicum, its construction method and the application of 3- hydracrylic acid | |
| CN106520655A (en) | Recombinant strain, method for preparing recombinant strain and method for producing L-valine from recombinant strain | |
| CN104480058A (en) | High yield L-leucine engineering bacterium and application thereof | |
| CN109402034A (en) | Only produce recombinant bacterium and its application of a kind of branched-chain amino acid | |
| CN103215286A (en) | Recombined DNA for fermenting to produce L-lysine, bacterial strain and application thereof | |
| CN102234666B (en) | Fed-batch fermentation preparation of lysine | |
| CN103642766A (en) | Protein, DNA molecule, conversion host containing DNA and method for production of L-valine by utilization of conversion host | |
| CN108728471A (en) | Produce the recombinant bacterium and the preparation method and application thereof of 3- hydracrylic acids | |
| CN106434510A (en) | Genetically engineered bacterium for producing L-aspartic acid through fermentation | |
| CN103114069B (en) | Bacterium for fermenting L-tryptophan from mixed saccharum and fermentation method thereof | |
| CN113122488B (en) | Klebsiella engineering bacteria and application thereof in producing glycerol and dihydroxyacetone | |
| CN102533626A (en) | Genetic engineering strain for producing succinic acid by utilizing glucose and acidogenic fermentation method thereof | |
| CN116333956A (en) | Corynebacterium glutamicum and method for producing L-valine by fermentation of corynebacterium glutamicum | |
| CN108504617A (en) | A kind of Escherichia coli recombinant strain and its construction method of high-yield L-lysine | |
| MX2015004180A (en) | Recombinant microorganisms for producing organic acids. | |
| CN104974946B (en) | Recombination bacillus coli resistant to high osmotic pressure and its application | |
| CN105969812A (en) | Method for preparing chiral (S)-acetoin by virtue of whole-cell biological catalysis | |
| CN103725718B (en) | Method for synthesizing acetoin and derivative thereof through biological method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |